News
New Financing Models May Expand Access to Life-Changing Cell and Gene Therapies
March 19, 2026
Featured Experts: Alison Sexton Ward, PhD, Elizabeth Fowler, PhD, JD, Jeremy L. Shane, Darius Lakdawalla, PhD
Research
All Research Featured Research
Perspective
Benchmarking Drug Prices to Inflation Overlooks What Truly Matters: Value
December 22, 2025
Featured Experts: William Padula, PhD
News
Schaeffer Scholar Receives 2025 ISPOR Research Methodology Award
October 24, 2025
Featured Experts: Boshen Jiao, PhD, MPH
Comment Letter
Response to the Draft Report of the Health Economics Methods Advisory (HEMA): “Defining Appropriate Benefits for Economic Evaluation of Health Care Technologies”
October 21, 2025
Featured Experts: Alice Chen, PhD, Jason Doctor, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Karen Mulligan, PhD, Desi Peneva, MS, Charles E. Phelps, PhD
News
USC Health Economist Darius Lakdawalla Elected to National Academy of Medicine
October 20, 2025
Featured Experts: Darius Lakdawalla, PhD
Journal Article
Measuring the Budget Impact of Nondiscriminatory Cost-Effectiveness
September 5, 2025
Featured Experts: Karen Mulligan, PhD, Drishti Baid, MPP, Maria-Alice Manetas, Darius Lakdawalla, PhD
Perspective
Should the Government Control Drug Prices? Yes… Wise Regulation Will Reform an Out-of-Control Industry
September 2, 2025
Featured Experts: Paul Ginsburg, PhD, Steven M. Lieberman, MPhil, MA
Journal Article
Long-Term Value of Lecanemab to Individuals and Families
August 28, 2025
Featured Experts: Bryan Tysinger, PhD, Hanke Heun-Johnson, PhD, Julie Zissimopoulos, PhD
Evidence Base
A Value-Based Price for Anti-Obesity Medications
July 17, 2025
Featured Experts: Alison Sexton Ward, PhD, Dana Goldman, PhD
Journal Article
Proposal for a Value-Based Agreement to Reimburse Anti-Obesity Medicines in Traditional Medicare
July 11, 2025
Featured Experts: Alison Sexton Ward, PhD, Erin Trish, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
Comment Letter
Comments to USTR on Foreign Nations Freeloading on American-Financed Innovation
June 27, 2025
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Barry Liden, JD
News
Why Do Americans Pay More for Prescription Drugs?
June 12, 2025
Featured Experts: Darius Lakdawalla, PhD
Perspective
Ensuring Most-Favored Nation Drug Pricing Doesn’t Sicken Us
May 20, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Perspective
The Biotech Industry Needs to Make Its Case for Bold Change to the White House
May 7, 2025
Featured Experts: Joseph Grogan, JD
Perspective
‘Most-Favored Nation’ Drug Pricing Has Three Significant Problems
April 14, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Perspective
How Regulatory Failures Have Crippled Dialysis Care
April 9, 2025
Featured Experts: Eugene Lin, MD, MS, Erin Trish, PhD
Perspective
A Missed Chance to Make America Healthier and Richer
April 7, 2025
Featured Experts: Alison Sexton Ward, PhD, Dana Goldman, PhD
News
Analysis Finds Meaningful Impact on Pharmaceutical Innovation From Reduced Revenues
February 18, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD, Karen Van Nuys, PhD
White Paper
The Elasticity of Pharmaceutical Innovation: How Much Does Revenue Drive New Drug Development?
February 18, 2025
Featured Experts: Karen Van Nuys, PhD, Darius Lakdawalla, PhD, Dana Goldman, PhD